BAVIS_1170x120_10-22-20

Lance Neill joins Rite Aid’s Elixir as COO

Print Friendly, PDF & Email

CAMP HILL, Pa. — Rite Aid’s Elixir subsidiary, which provides pharmacy benefits and services, said Tuesday that veteran healthcare and pharmacy executive Lance Neill has joined the company as chief operating officer.

Neill was most recently vice president of network development and contracting for Centene’s portfolio of managed care products, representing $32 billion in annual pharmacy spend. Prior to that, he served in multiple senior leadership roles with major healthcare brands including Diplomat Pharmacy and Walmart.

ElixirLance brings substantial experience in pharmacy network development and contracting, specialty pharmacy, finance, analytics and operational oversight to his new role. At Elixir, he will oversee the unit’s core operational functions, including Elixir Insurance. He will also be responsible for Elixir’s strategic development, ensuring that the company remains positioned for continued innovation and growth.

“Elixir’s opportunities have never been more compelling,” Neill said. “It is clear that regional health plans and mid-market employers are looking for a more surefooted approach to managing pharmacy spend and driving better health outcomes. And it is clear that as part of the Rite Aid enterprise, Elixir offers significant differentiation in target markets. I am excited to join a purpose-driven company, that is committed to helping people achieve whole health for life.”

Rite Aid president and chief executive officer Heyward Donigan hailed the appointment.

“Elixir is a critical component of Rite Aid’s growth strategy, and we are doubling down on our investment to position the company as a market leader,” Donigan said. “Lance is a seasoned and trusted industry executive who consistently delivers results. He is uniquely qualified to drive strategic prioritization and accountability within Elixir, with a laser focus on operational excellence. In the months to come, I will work closely with Lance and the rest of the Elixir executive team to continue our march forward.”

 


SATIS_728x90_1-25-21

FREUD_728x90_6-19-20

Comments are closed.